3977131

Raman spectroscopy as a multi attribute PAT tool for real time monitoring of Critical Quality Attributes in Biologics

Date
March 19, 2024
Explore related products in the following collection:

With increasing focus on implementation of continuous processing for manufacturing of biopharmaceutical products, there is an urgent requirement for tools that enable inline process monitoring. At present, significant time and resources are invested on monitoring CQAs during in-process stages of downstream manufacturing. In this study, we demonstrate an application of Raman spectroscopy as a multi-attribute PAT (process analytical technology) tool for estimation of protein concentration as well as size/charge based heterogeneities during purification of a monoclonal antibody biotherapeutic product. Pre-processing using standard normal variate (SNV) and Salvitzky – Golay smoothening was able to reduce the fluorescence interference and offset in the data set, that are known challenges while working with Raman spectra. Advanced chemometrics has been applied to the Raman data for measurement of other attributes - the first based on a Bayesian optimised support vector machines (SVM) methodology using the Gaussian kernel and the second on using random forest with feature selection by K-means clustering. Both approaches offered significant improvement over the conventional PLS, especially in aggregate prediction. The tool was successfully validated at all in-process stages with four IgGs for aggregate prediction with R2 of 0.93 and RMSE of 0.37 under a broad calibration range of 0-7% high molecular weight species. Other attributes such as charge variants (acidic%/basic%) and protein concentration were also predicted successfully and validated for both trained and untrained IgG molecules. We hope that this study will encourage manufacturers for using Raman as a PAT tool for multi-attribute measurement.

Related Products

Thumbnail for Intensified downstream connected processing of mAbs: PD to scale up for robust, cost effective, and agile manufacturing
Intensified downstream connected processing of mAbs: PD to scale up for robust, cost effective, and agile manufacturing
Connected processing is an intensification strategy where multiple operations are connected and processed in parallel enabling the manufacturer to achieve higher productivity, while keeping time and cost low…
Thumbnail for End-to-end innovative product development and supply to meet the needs of women in low- and middle-income countries
End-to-end innovative product development and supply to meet the needs of women in low- and middle-income countries
As we consider the evolving needs of people living in low-and-middle income countries (LMICs), we need to re-think how we can help them meet their health goals. To do so, we need to consider the entire system from drug development through supply…
Thumbnail for Democratization of protein-based drug and vaccine supply through regional small-footprint manufacturing
Democratization of protein-based drug and vaccine supply through regional small-footprint manufacturing
Local biomanufacturing capacity could transform access to therapeutics in low- and middle-income countries (LMICs) by promoting self-sufficiency to address current and future needs for biologic drugs and vaccines, ultimately improving both regional livelihoods and health outcomes…
Thumbnail for mRNA drugs production from very small to very large-scale capacity: when to use batch versus continuous strategies
mRNA drugs production from very small to very large-scale capacity: when to use batch versus continuous strategies
The modern industrial biomanufacturing can be divided into three main principles: batch, fed-batch, and continuous processes…